Cost-effectiveness of lenvatinib plus pembrolizumab versus chemotherapy for recurrent mismatch repair-proficient endometrial cancer after platinum-based therapy

Autor: Dioun, Shayan, Chen, Ling, De Meritens, Alexandre Buckley, St. Clair, Caryn M., Hou, June Y., Khoury-Collado, Fady, Pua, Tarah, Hershman, Dawn L., Wright, Jason D.
Zdroj: In Gynecologic Oncology March 2024 182:70-74
Databáze: ScienceDirect
Externí odkaz: